90/015,528Infusion System Configured for Transfer of Data8,998,100Open

Status

Appeal Brief Filed (or Remand from Board) - Awaiting Examiner Action

Filed

Sep 19, 2025

Last Updated

Jul 16, 2026

Art Unit

3992

Requester Law Firm

K&L Gates LLP

Requested By

Third Party

Patent Owner(via USPTO assignment records)

CareFusion 303, Inc.

Patent Owner Law Firm

MINTZ LEVIN / CareFusion

Sector (CPC)

GPhysics & Instruments
G16Bioinformatics
G16HHealthcare Informatics

USPC

235Registers

Reexam History (52 events)

Aug 24, 2026WIDSInformation Disclosure Statement (IDS) Filed
Aug 24, 2026RXC/SRCertificate of Service
Jul 16, 2026RXAP.BAppeal Brief Filed
Jul 16, 2026RXC/SRCertificate of Service
Jul 16, 2026RXAPBRAppeal Brief Review Complete
Jul 6, 2026WIDSInformation Disclosure Statement (IDS) Filed
Jul 6, 2026RXC/SRCertificate of Service
May 28, 2026MR327RX - Mail Miscellaneous Communication to Applicant
May 27, 2026IDSCInformation Disclosure Statement considered
May 27, 2026IDSCInformation Disclosure Statement considered
May 19, 2026WIDSInformation Disclosure Statement (IDS) Filed
May 19, 2026RXIDS.Information Disclosure Statement Filed
May 19, 2026RXC/SRCertificate of Service
May 18, 2026RXN/APNotice of Appeal Filed
May 18, 2026RXC/SRCertificate of Service
Apr 21, 2026MRXFRRX - Mail Final Rejection
Apr 14, 2026IDSCInformation Disclosure Statement considered
Mar 27, 2026RXC/SRCertificate of Service
Mar 27, 2026RXA...Response after Non-Final Action
Mar 23, 2026WIDSInformation Disclosure Statement (IDS) Filed
Mar 23, 2026RXC/SRCertificate of Service
Jan 29, 2026MR.NFRX - Mail Reexam Non-Final Action
Jan 27, 2026RXC/SRCertificate of Service
Jan 27, 2026WIDSInformation Disclosure Statement (IDS) Filed
Jan 27, 2026WIDSInformation Disclosure Statement (IDS) Filed
Jan 27, 2026RXIDS.Information Disclosure Statement Filed
Jan 27, 2026RXLET.Miscellaneous Incoming Letter
Jan 22, 2026IDSCInformation Disclosure Statement considered
Dec 2, 2025RXFWDXDate Forwarded to Examiner
Nov 6, 2025RXLET.Miscellaneous Incoming Letter
Nov 6, 2025WIDSInformation Disclosure Statement (IDS) Filed
Nov 6, 2025RXC/SRCertificate of Service
Oct 14, 2025MRPWPRX - Mail Pilot Waiver Program - Ex Parte Interview Summary
Oct 7, 2025RXLITSRReexam Litigation Search Conducted
Sep 30, 2025MREXORX - Mail Ex Parte Request for Reexamination Granted
Sep 25, 2025IDSCInformation Disclosure Statement considered
Sep 24, 2025MRXNReexamination Formalities Notice Mailed
Sep 24, 2025DOCKCase Docketed to Examiner in GAU
Sep 24, 2025MRXNReexamination Formalities Notice Mailed
Sep 24, 2025COMPApplication Is Now Complete
Sep 23, 2025RXPCOMCompletion of Preprocessing - Released to Assigned GAU
Sep 23, 2025RXNREQFDNotice of reexamination request filing date
Sep 23, 2025RXNREQAUNotice of assignment of reexamination request
Sep 22, 2025PRXRParalegal Reexam Review Complete
Sep 22, 2025FTFIFITF set to NO - revise initial setting
Sep 22, 2025RXTTLRPTTitle Report
Sep 19, 2025BIG.Entity Status Set To Undiscounted (Initial Default Setting or Status Change)
Sep 19, 2025RXO_40.RReceipt of Orig. Ex Parte Request by Third Party Less Than 40 Pages - Rule 1.20(c )(1)
Sep 19, 2025WIDSInformation Disclosure Statement (IDS) Filed
Sep 19, 2025RXOSUBReceipt of Original Ex Parte Reexam Request
Sep 19, 2025RXIDS.RReexam - Information Disclosure Statement Filed by Third Party Requester
Sep 19, 2025RXC/SRCertificate of Service

Prosecution, PTAB & CAFC

PTAB Proceedings (IPR, PGR, CBM, DER)

None found

Federal Circuit (CAFC)

None found

Terminal Disclaimer

None found

Prosecution History

None found

Maintenance Fees

Grant
Apr 7, 2015
3.5-yr
Oct 7, 2018
Paid Sep 21, 2018
7.5-yr
Oct 7, 2022
Paid Sep 20, 2022
11.5-yr
Oct 7, 2026
Expiry
Jun 26, 2033

Entity Status

Large Entity

Expires

Jun 26, 2033 (7.2 yr remaining)

Assignments

Jun 2013Jul 2013FiledSTEPHEN BOLLISHDONALD HALBERTTIMOTHY W. VANDERVEENCAREFUSION 303, INC.
AssignmentReel/Frame: 031185/0298Recorded: Sep 11, 2013

From

STEPHEN BOLLISHInventor
Jun 21, 2013
DONALD HALBERTInventor
Jun 21, 2013
TIMOTHY W. VANDERVEENInventor
Jun 27, 2013
→

To

CAREFUSION 303, INC.